Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Learn Mem ; 157: 151-162, 2019 01.
Article in English | MEDLINE | ID: mdl-30521850

ABSTRACT

Numerous preclinical studies show that acute cannabinoid administration impairs cognitive performance. Almost all of this research has employed cannabinoid injections, however, whereas smoking is the preferred route of cannabis administration in humans. The goal of these experiments was to systematically determine how acute exposure to cannabis smoke affects working memory performance in a rat model. Adult male (n = 15) and female (n = 16) Long-Evans rats were trained in a food-motivated delayed response working memory task. Prior to test sessions, rats were exposed to smoke generated by burning different numbers of cannabis or placebo cigarettes, using a within-subjects design. Exposure to cannabis smoke had no effect on male rats' performance, but surprisingly, enhanced working memory accuracy in females, which tended to perform less accurately than males under baseline conditions. In addition, cannabis smoke enhanced working memory accuracy in a subgroup of male rats that performed comparably to the worst-performing females. Exposure to placebo smoke had no effect on performance, suggesting that the cannabinoid content of cannabis smoke was critical for its effects on working memory. Follow-up experiments showed that acute administration of either Δ9-tetrahydrocannabinol (0.0, 0.3, 1.0, 3.0 mg/kg) or the cannabinoid receptor type 1 antagonist rimonabant (0.0, 0.2, 0.6, 2.0 mg/kg) impaired working memory performance. These results indicate that differences in the route, timing, or dose of cannabinoid administration can yield distinct cognitive outcomes, and highlight the need for further investigation of this topic.


Subject(s)
Cannabinoids/administration & dosage , Cannabis , Marijuana Smoking/psychology , Memory, Short-Term/drug effects , Animals , Cannabidiol/administration & dosage , Cannabinol/administration & dosage , Choice Behavior/drug effects , Dronabinol/administration & dosage , Female , Male , Rats, Long-Evans
2.
eNeuro ; 5(4)2018.
Article in English | MEDLINE | ID: mdl-30073194

ABSTRACT

Brain imaging studies indicate that chronic cocaine users display altered functional connectivity between prefrontal cortical, thalamic, striatal, and limbic regions; however, the use of cross-sectional designs in these studies precludes measuring baseline brain activity prior to cocaine use. Animal studies can circumvent this limitation by comparing functional connectivity between baseline and various time points after chronic cocaine use. In the present study, adult male Long-Evans rats were trained to self-administer cocaine intravenously for 6 h sessions daily over 14 consecutive days. Two additional groups serving as controls underwent sucrose self-administration or exposure to the test chambers alone. Functional magnetic resonance imaging was conducted before self-administration and after 1 and 14 d of abstinence (1d and 14d Abs). After 1d Abs from cocaine, there were increased clustering coefficients in brain areas involved in reward seeking, learning, memory, and autonomic and affective processing, including amygdala, hypothalamus, striatum, hippocampus, and thalamus. Similar changes in clustering coefficient after 1d Abs from sucrose were evident in predominantly thalamic brain regions. Notably, there were no changes in strength of functional connectivity at 1 or 14 d after either cocaine or sucrose self-administration. The results suggest that cocaine and sucrose can change the arrangement of functional connectivity of brain regions involved in cognition and emotion, but that these changes dissipate across the early stages of abstinence. The study also emphasizes the importance of including baseline measures in longitudinal functional neuroimaging designs seeking to assess functional connectivity in the context of substance use.


Subject(s)
Cocaine-Related Disorders/physiopathology , Cocaine/pharmacology , Corpus Striatum , Dopamine Uptake Inhibitors/pharmacology , Limbic System , Neocortex , Nerve Net , Sucrose/pharmacology , Sweetening Agents/pharmacology , Animals , Cocaine/administration & dosage , Cocaine-Related Disorders/diagnostic imaging , Connectome/methods , Corpus Striatum/diagnostic imaging , Corpus Striatum/drug effects , Corpus Striatum/physiopathology , Disease Models, Animal , Dopamine Uptake Inhibitors/administration & dosage , Limbic System/diagnostic imaging , Limbic System/drug effects , Limbic System/physiopathology , Magnetic Resonance Imaging , Male , Neocortex/diagnostic imaging , Neocortex/drug effects , Neocortex/physiopathology , Nerve Net/diagnostic imaging , Nerve Net/drug effects , Nerve Net/physiopathology , Rats , Rats, Long-Evans , Self Administration , Sucrose/administration & dosage , Sweetening Agents/administration & dosage
3.
Neuropharmacology ; 139: 205-216, 2018 09 01.
Article in English | MEDLINE | ID: mdl-30009836

ABSTRACT

The prefrontal cortex (PFC) plays an important role in several forms of cost-benefit decision making. Its contributions to decision making under risk of explicit punishment, however, are not well understood. A rat model was used to investigate the role of the medial PFC (mPFC) and its monoaminergic innervation in a Risky Decision-making Task (RDT), in which rats chose between a small, "safe" food reward and a large, "risky" food reward accompanied by varying probabilities of mild footshock punishment. Inactivation of mPFC increased choice of the large, risky reward when the punishment probability increased across the session ("ascending RDT"), but decreased choice of the large, risky reward when the punishment probability decreased across the session ("descending RDT"). In contrast, enhancement of monoamine availability via intra-mPFC amphetamine reduced choice of the large, risky reward only in the descending RDT. Systemic administration of amphetamine reduced choice of the large, risky reward in both the ascending and descending RDT; however, this reduction was not attenuated by concurrent mPFC inactivation, indicating that mPFC is not a critical locus of amphetamine's effects on risk taking. These findings suggest that mPFC plays an important role in adapting choice behavior in response to shifting risk contingencies, but not necessarily in risk-taking behavior per se.


Subject(s)
Decision Making/physiology , Prefrontal Cortex/physiology , Punishment , Risk-Taking , Amphetamine/pharmacology , Animals , Biogenic Monoamines/metabolism , Decision Making/drug effects , Feeding Behavior/drug effects , Feeding Behavior/physiology , Feeding Behavior/psychology , Male , Neurotransmitter Uptake Inhibitors/pharmacology , Prefrontal Cortex/drug effects , Psychotropic Drugs/pharmacology , Rats, Long-Evans
4.
Behav Brain Res ; 321: 130-136, 2017 03 15.
Article in English | MEDLINE | ID: mdl-28057530

ABSTRACT

Chronic administration of cocaine can cause pronounced and enduring cognitive alterations such as increases in impulsive choice. Chronic cocaine can also result in enhanced dopamine (DA) release in the nucleus accumbens (NAc) in response to reward-related cues. It is possible that this enhanced DA release in the NAc is a mechanism by which cocaine increases impulsive choice. To date, however, the specific role of DA in the NAc in impulsive choice is unclear. To begin to address this, rats received acute microinjections of the indirect DA agonist amphetamine directly into the NAc prior to testing in a delay discounting task in which rats chose between a small, immediate and a large, delayed food reward. When delays to the large reward increased within test sessions, amphetamine increased choice of the large reward. When delays decreased within test sessions, however, amphetamine decreased choice of the large reward. These findings suggest that, rather than specifically mediating impulsive choice, DA neurotransmission in the NAc is necessary for flexible adaptation of choice strategies in the presence of shifting reward contingencies. These results further indicate that enhancements in NAc DA release likely do not account for lasting increases in impulsive choice caused by chronic cocaine.


Subject(s)
Amphetamine/pharmacology , Delay Discounting/drug effects , Dopamine Agents/pharmacology , Nucleus Accumbens/drug effects , Analysis of Variance , Animals , Delay Discounting/physiology , Dopamine/metabolism , Dose-Response Relationship, Drug , Impulsive Behavior/drug effects , Impulsive Behavior/physiology , Male , Microinjections , Nucleus Accumbens/metabolism , Psychological Tests , Rats, Long-Evans , Reward
SELECTION OF CITATIONS
SEARCH DETAIL
...